Efficacy of Kinesiotape on Treatment of Nonspecific Cardiac Chest Pain

NCT06350188 | Active Not Recruiting

• 1 other identifier: ECM#2024-506
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

purpose of the study To investigate the effect of Kinesio-tape on treatment of nonspecific cardiac chest pain

Conditions

Nonspecific Cardiac Chest Pain

Outcome Measures

Primary Outcomes (1)

• PAIN USING VIISUSL ANALOGE SCALE

  cm line with 0 (no pain) and 10 (killing pain). The patient places a mark along the line to detect his chest pain level.

  up to 2 weeks

Secondary Outcomes (1)

• PERSSURE PAIN THRESHOLD

  up to 2 weeks

Other Outcomes (2)

• SHOULDER RANGE OF MOTION

  up to 2 weeks

• shoulder pain and disability

  up to 2 weeks

Study Arms (2)

experimental

EXPERIMENTAL

the patient will receive kinsiotape therapy

Other: experimental

traditional

ACTIVE COMPARATOR

the patient will receive traditional therapy

Other: traditional

Interventions

experimental OTHER

15 patients ˃receive kinisio-tape ,2 session / week for 2 weeks. Followed by stretching exercises, they will be assessed pre and immediately post application, after two weeks and follow up after one month

experimental

traditional OTHER

15 patients ˃ will receive ischemic pressure release followed by stretching exercises 2 session / week for 2 weeks, will be assessed pre and immediately post application, after two weeks and follow up after one month.

traditional

Eligibility Criteria

• Age: 20 Years - 35 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• subjects from both sexes with nonspecific cardiac chest pain 2- Rhomboid trigger point 3-All subjects range from 7 to 9 on VAS. 4-Age range from 20-35. 5- All subjects will complain from limited shoulder ROM

You may not qualify if:

• Acute coronary syndrome/ ischemic heart disease 2-Pleurisy 3-Pulmonary lessons like(COPD) Chronic Obstructive Pulmonary Disease,( COAD) Chronic Obstructive Airway Disease and Bronchiectasis, 4-Costochondritis, ' 5-Teitze syndrome, 6-Chest wall syndrome 7-Rheumatologic conditions, 8-Infections in the chest wall 9-Gastro-intestinal problems and 10-Neoplastic disorders

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Huda Badr Abd Elhamed

Cairo, Egypt

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: principle investigator

Study Record Dates

• First Submitted: April 1, 2024
• First Posted: April 5, 2024
• Study Start: March 22, 2024
• Primary Completion: June 22, 2024
• Study Completion: July 22, 2024
• Last Updated: April 5, 2024

Record last verified: 2024-04

Locations

EG (1)